keyword
https://read.qxmd.com/read/38631574/research-trends-of-bio-application-of-major-components-in-lignocellulosic-biomass-cellulose-hemicellulose-and-lignin-in-orthopedics-fields-based-on-the-bibliometric-analysis-a-review
#21
REVIEW
Wenhui Pei, Yuxin Yu, Peng Wang, Liming Zheng, Kai Lan, Yongcan Jin, Qiang Yong, Caoxing Huang
Cellulose, hemicellulose, and lignin are the major bio-components in lignocellulosic biomass (BC-LB), which possess excellent biomechanical properties and biocompatibility to satisfy the demands of orthopedic applications. To understand the basis and trends in the development of major bio-components in BC-LB in orthopedics, the bibliometric technology was applied to get unique insights based on the published papers (741) in the Web of Science (WOS) database from January 1st, 2001, to February 14th, 2023. The analysis includes the annual distributions of publications, keywords co-linearity, research hotspots exploration, author collaboration networks, published journals, and clustering of co-cited literature...
April 15, 2024: International Journal of Biological Macromolecules
https://read.qxmd.com/read/38631282/biomembrane-camouflaged-nanoparticles-a-paradigm-shifts-in-targeted-drug-delivery-system
#22
REVIEW
Saba Asif Qureshi, Km Rafiya, Sakshi Awasthi, Abhishek Jain, Arif Nadaf, Nazeer Hasan, Prashant Kesharwani, Farhan Jalees Ahmad
Targeted drug delivery has emerged as a pivotal approach within precision medicine, aiming to optimize therapeutic efficacy while minimizing systemic side effects. Advanced biomimetic membrane-coated formulations have garnered significant interest from researchers as a promising strategy for targeted drug delivery, site-specific accumulation and heightened therapeutic outcomes. Biomimetic nanotechnology is able to retain the biological properties of the parent cell thus are able to exhibit superior targeting compared to conventional formulations...
April 4, 2024: Colloids and Surfaces. B, Biointerfaces
https://read.qxmd.com/read/38631250/empowering-hydrophobic-anticancer-drugs-by-ultrashort-peptides-general-co-assembly-strategy-for-improved-solubility-targeted-efficacy-and-clinical-application
#23
JOURNAL ARTICLE
Feng Gao, Jun Guo, Shihao Liu, Feng Zhang, Yi Zhang, Liping Wang
The current state of drug delivery systems allows for the resolution of specific issues like inadequate solubility, limited targeting capabilities, and complex preparation processes, requiring tailored designs for different drugs. Yet, the major challenge in clinical application lies in surmounting these obstacles with a universal carrier that is effective for a variety of anticancer drugs. Herein, with the help of computer simulation, we rationally design ultrashort peptides GY and CCYRGD, which can co-assemble with hydrophobic anticancer drugs into nanoparticles with enhanced solubility, targeting ability and anticancer efficacy...
April 3, 2024: Journal of Colloid and Interface Science
https://read.qxmd.com/read/38630860/design-of-dry-powder-inhalers-to-improve-patient-outcomes-it-s-not-just-about-the-device
#24
REVIEW
Jeffry G Weers
INTRODUCTION: Up to 50% of asthma/COPD patients make critical errors in dose preparation and dose inhalation with current marketed DPIs which negatively impact clinical outcomes. Others fail to adhere to their chronic treatment regimen. AREAS COVERED: For this review, we describe how a human-factors approach to design of a dry powder inhaler can be used to improve usability, proficiency, and functionality of DPIs, while effectively mitigating critical errors associated with DPIs...
April 17, 2024: Expert Opinion on Drug Delivery
https://read.qxmd.com/read/38630254/exploring-the-potential-of-silymarin-loaded-nanovesicles-as-an-effective-drug-delivery-system-for-cancer-therapy-in-vivo-in-vitro-and-in-silico-experiments
#25
JOURNAL ARTICLE
Mohammad Reza Hajinezhad, Maryam Roostaee, Zahra Nikfarjam, Sanaz Rastegar, Ghasem Sargazi, Mahmood Barani, Saman Sargazi
We aimed to perform a comprehensive study on the development and characterization of silymarin (Syl)-loaded niosomes as potential drug delivery systems. The results demonstrate significant novelty and promising outcomes in terms of morphology, size distribution, encapsulation efficiency, in vitro release behavior, free energy profiles of Syl across the niosome bilayer, hydrogen bonding interactions, antimicrobial properties, cytotoxicity, and in vivo evaluations. The physical appearance, size, and morphology assessment of free niosomes and Syl-loaded niosomes indicated stable and well-formed vesicular structures suitable for drug delivery...
April 17, 2024: Naunyn-Schmiedeberg's Archives of Pharmacology
https://read.qxmd.com/read/38629738/cytisine-eye-drops-for-benzalkonium-chloride-induced-dry-eye-safety-and-efficacy-evaluation
#26
JOURNAL ARTICLE
Zijian Wang, Xixi Song, Yanjun Wei, Xianggen Wu, Ying Jie
This experiment aimed to investigate the feasibility of cytisine (CYT) in treating eye diseases with ocular topical application. An in vitro cytotoxicity test, a hen's egg test-chorioallantoic membrane (HET-CAM), and a mouse eye tolerance test were used to fully reveal the ocular safety profiles of CYT. For the efficacy evaluations, CYT's effects on cell wound healing, against H2 O2 -induced oxidative stress damages on cells, and on benzalkonium chloride (BAC)-induced dry eye disease (DED) in mice were evaluated...
April 17, 2024: Pharmaceutical Development and Technology
https://read.qxmd.com/read/38629735/overcoming-the-blood-brain-tumor-barrier-with-docetaxel-loaded-mesoporous-silica-nanoparticles-for-treatment-of-temozolomide-resistant-glioblastoma
#27
JOURNAL ARTICLE
Tsung-I Hsu, Yi-Ping Chen, Rong-Lin Zhang, Zih-An Chen, Cheng-Hsun Wu, Wen-Chang Chang, Chung-Yuan Mou, Hardy Wai-Hong Chan, Si-Han Wu
While temozolomide (TMZ) has been a cornerstone in the treatment of newly diagnosed glioblastoma (GBM), a significant challenge has been the emergence of resistance to TMZ, which compromises its clinical benefits. Additionally, the nonspecificity of TMZ can lead to detrimental side effects. Although TMZ is capable of penetrating the blood-brain barrier (BBB), our research addresses the need for targeted therapy to circumvent resistance mechanisms and reduce off-target effects. This study introduces the use of PEGylated mesoporous silica nanoparticles (MSN) with octyl group modifications (C8-MSN) as a nanocarrier system for the delivery of docetaxel (DTX), providing a novel approach for treating TMZ-resistant GBM...
April 17, 2024: ACS Applied Materials & Interfaces
https://read.qxmd.com/read/38629397/tabletized-nanomedicine-from-the-current-scenario-to-developing-future-medicine
#28
REVIEW
Rahul Tiwari, Meghana Kolli, Sumeet Chauhan, Murali M Yallapu
The limitations of conventional therapeutic treatments prevailed in the development of nanotechnology-based medical formulations, termed nanomedicine. Nanomedicine is an advanced medicine that often consists of therapeutic agent(s) embedded in biodegradable or biocompatible nanomaterial-based formulations. Among nanomedicine approaches, tablet (oral) nanomedicine is still under development. In tabletized nanomedicine, the dynamic interplay between nanoformulations and the intricate milieu of the gastrointestinal tract simulates a pivotal role, particularly accentuating the influence exerted upon the luminal, mucosal, and epithelial cells...
April 17, 2024: ACS Nano
https://read.qxmd.com/read/38629385/role-of-non-receptor-tyrosine-kinases-in-epilepsy-significance-and-potential-as-therapeutic-targets
#29
REVIEW
Ozasvi R Shanker, Sonali Kumar, Jyotirmoy Banerjee, Manjari Tripathi, P Sarat Chandra, Aparna Banerjee Dixit
INTRODUCTION: Epilepsy is a chronic neurological condition characterized by a persistent propensity for seizure generation. About one-third of patients do not achieve seizure control with the first-line treatment options, which include > 20 antiseizure medications. It is therefore imperative that new medications with novel targets and mechanisms of action are developed. AREAS COVERED: Clinical studies and preclinical research increasingly implicate Non-receptor tyrosine kinases (nRTKs) in the pathogenesis of epilepsy...
April 17, 2024: Expert Opinion on Therapeutic Targets
https://read.qxmd.com/read/38629372/the-hgf-met-receptor-mediates-cytotoxic-effect-of-bacterial-cyclodipeptides-in-human-cervical-cancer-cells
#30
JOURNAL ARTICLE
Laura Hernández-Padilla, Mayra X Durán-Maldonado, Lorena Martínez-Alcantar, José S Rodríguez-Zavala, Jesus Campos-Garcia
BACKGROUND: Human cervix adenocarcinoma (CC) caused by papillomavirus is the third most common cancer among female malignant tumors. Bioactive compounds such as cyclodipeptides (CDPs) possess cytotoxic effects in human cervical cancer HeLa cells mainly by blocking the PI3K/Akt/mTOR pathway and subsequently inducing gene expression by countless transcription regulators. However, the upstream elements of signaling pathways have not been well studied. METHODS: To elucidate the cytotoxic and antiproliferative responses of the HeLa cell line to CDPs by a transcriptomic analysis previously carried out, we identified by immunochemical analyses, differential expression of genes related to the hepatocyte growth factor/mesenchymal-epithelial transition factor (HGF/MET) receptors...
April 15, 2024: Current Cancer Drug Targets
https://read.qxmd.com/read/38629371/translation-research-in-therapeutic-approaches-from-conventional-to-novel-nano-therapeutics-for-rheumatoid-arthritis-treatment
#31
JOURNAL ARTICLE
Laxmi Rani, Pooja Mathur, Ravinder Verma, Vivek Kumar, Ashwini Kumar Mishra, Pravat Kumar Sahoo
Rheumatoid arthritis is a systemic autoimmune disorder related to joint inflammation, bone erosion, and deformity. Numerous studies indicate that the causes and consequences of RA are still being debated, and therapeutic strategies are in the translation stage. Non-steroidal anti-inflammatory drugs continue to be often used to relieve pain. Still, due to their poor efficacy, failure to halt the spread of the disease, and undesirable adverse effects, they are no longer regarded as first-line treatments. The development of biologic DMRDs designed to reduce the inflammatory response led to substantial changes to the strategy for managing this disease...
April 15, 2024: Current Rheumatology Reviews
https://read.qxmd.com/read/38629367/gold-nanoparticle-based-drug-delivery-system-for-the-diagnosis-and-treatment-of-bacterial-meningitis
#32
JOURNAL ARTICLE
Darsh Gautam, Vinay Pandit, Sanjay Kumar, Poonam Talwan, Tarun Sharma
Managing bacterial pathogens in the central nervous system is an immense issue for researchers all around the globe. The problem of these infections remains throughout the population, regardless of the discovery of several possible medicines. The major obstacle to drug delivery is the BBB, but only a few medicines that fulfill demanding requirements can penetrate it. Considering inadequate antibiotic alternatives and the increasing development of resistance, it is more important than ever to find new approaches to address this worldwide problem...
April 16, 2024: Current Drug Delivery
https://read.qxmd.com/read/38629360/therapeutic-strategies-to-improve-the-treatment-of-pleural-mesothelioma
#33
JOURNAL ARTICLE
Luca Mirra, Giovanni L Beretta, Daniela Lisini, Angela Marcianti, Eleonora Spampinato, Cristina Corno, Matteo Costantino, Angelo Corsico, Giulia Maria Stella, Paola Perego
Pleural mesothelioma is a rare neoplastic disease with aggressive features. Patient survival is poor due to the lack of early symptoms and the absence of effective therapeutic strategies. The development of pleural mesothelioma is mainly associated with asbestos exposure and related chronic inflammation. From a molecular-based perspective, this disease is a heterogeneous tumor lacking actionable alterations. The median overall survival of patients affected by this tumor does not exceed 16 months from diagnosis...
April 16, 2024: Current Medicinal Chemistry
https://read.qxmd.com/read/38629354/patient-centric-approaches-revolutionizing-rare-disease-drug-research
#34
EDITORIAL
Abhishek Verma, Ankit Awasthi
No abstract text is available yet for this article.
April 16, 2024: Infectious Disorders Drug Targets
https://read.qxmd.com/read/38629192/recent-developments-in-the-use-of-nanocrystals-to-improve-bioavailability-of-apis
#35
REVIEW
Yidan Ding, Tongyi Zhao, Jianing Fang, Jiexin Song, Haobo Dong, Jiarui Liu, Sijin Li, Min Zhao
Nanocrystals refer to materials with at least one dimension smaller than 100 nm, composing of atoms arranged in single crystals or polycrystals. Nanocrystals have significant research value as they offer unique advantages over conventional pharmaceutical formulations, such as high bioavailability, enhanced targeting selectivity and controlled release ability and are therefore suitable for the delivery of a wide range of drugs such as insoluble drugs, antitumor drugs and genetic drugs with broad application prospects...
2024: Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology
https://read.qxmd.com/read/38629152/promising-therapeutic-targets-for-the-treatment-of-urine-storage-dysfunction-what-s-the-status
#36
REVIEW
Karl-Erik Andersson
INTRODUCTION: Opinions differ on what drugs have both a rationale and a development potential for the treatment of bladder storage dysfunction. AREAS COVERED: In the present review, the focus is given to small molecule blockers of TRP channels (TRPV1, TRPV4, TRPA1, and TRPM8), P2×3receptor antagonists, drugs against oxidative stress, antifibrosis agents, cyclic nucleotide - dependent pathways, and MaxiK±channel - gene therapy. EXPERT OPINION: TRPV1 channel blockers produce hypothermia which seems to be a problem even with the most efficacious second-generation TRPV1 antagonists...
April 17, 2024: Expert Opinion on Therapeutic Targets
https://read.qxmd.com/read/38629000/neonatal-outcomes-in-labor-after-intravenous-remifentanil-analgesia-vs-epidural-analgesia-a-retrospective-observational-study
#37
JOURNAL ARTICLE
Suzana Sobot Novakovic, Sanja Cuk, Dragan Rakanovic, Dragana Loncar Stojiljkovic, Branka Cancarevic Djajic, Miroslav Gajic
Background Some evidence indicates that maternal analgesia during labor may have adverse effects on neonates due to exposure to specific drugs or the potential effects of analgesia on the course of labor. We assessed the clinical outcome of term neonates born to mothers who received epidural analgesia (E) or systemic analgesia with remifentanil (R) during labor. Methods Data was collected retrospectively over one year. We have evaluated the medical records of 247 full-term neonates; 208 were born to mothers who received E and 39 to mothers who received R...
March 2024: Curēus
https://read.qxmd.com/read/38628892/characterization-and-evaluation-of-nano-niosomes-encapsulating-docetaxel-against-human-breast-pancreatic-and-pulmonary-adenocarcinoma-cancer-cell-lines
#38
JOURNAL ARTICLE
Mohammadreza Ajdari, Aliyeh Ranjbar, Khashayar Karimian, Maryam Karimi, Hossein Heli, Naghmeh Sattarahmady
BACKGROUND: Docetaxel (DXL) is an antineoplastic agent for cancer treatment, the therapeutic efficiency of which is limited due to low solubility, hydrophobicity, and tissue specificity. OBJECTIVE: In this study, nano-niosomes were introduced for improving therapeutic index of DXL. MATERIAL AND METHODS: In this experimental study, two nano-niosomes were synthesized using Span 20® and Span 80® and a thin film hydration method with DXL loading (DXL-Span20 and DXL-Span80)...
April 2024: Journal of Biomedical Physics & Engineering
https://read.qxmd.com/read/38628721/a-comprehensive-review-on-the-biomedical-frontiers-of-nanowire-applications
#39
REVIEW
Juhi Jannat Mim, Mehedi Hasan, Md Shakil Chowdhury, Jubaraz Ghosh, Md Hosne Mobarak, Fahmida Khanom, Nayem Hossain
This comprehensive review examines the immense capacity of nanowires, nanostructures characterized by unbounded dimensions, to profoundly transform the field of biomedicine. Nanowires, which are created by combining several materials using techniques such as electrospinning and vapor deposition, possess distinct mechanical, optical, and electrical properties. As a result, they are well-suited for use in nanoscale electronic devices, drug delivery systems, chemical sensors, and other applications. The utilization of techniques such as the vapor-liquid-solid (VLS) approach and template-assisted approaches enables the achievement of precision in synthesis...
April 30, 2024: Heliyon
https://read.qxmd.com/read/38628650/different-therapeutic-approaches-in-melasma-advances-and-limitations
#40
REVIEW
Parisa Ghasemiyeh, Rahil Fazlinejad, Mohammad Reza Kiafar, Shiva Rasekh, Mohammad Mokhtarzadegan, Soliman Mohammadi-Samani
Melasma is a chronic hyperpigmentation skin disorder that is more common in the female gender. Although melasma is a multifactorial skin disorder, however, sun-exposure and genetic predisposition are considered as the main etiologic factors in melasma occurrence. Although numerous topical and systemic therapeutic agents and also non-pharmacologic procedural treatments have been considered in melasma management, however, the commonly available therapeutic options have several limitations including the lack of sufficient clinical effectiveness, risk of relapse, and high rate of unwanted adverse drug reactions...
2024: Frontiers in Pharmacology
keyword
keyword
28585
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.